Real-World Evidence Study of Patients with

Anna Anttalainen, Paavo Pietarinen, Samuli Tuominen, Riikka Mattila, Aino Mutka, Aija Knuuttila

Abstract read

In one paragraph

Article in Current oncology (Toronto, Ont.), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it

0cells of the map it votes in

1citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

Metastatic NSCLC patients in the real world in Finland.Acta oncologica (Stockholm, Sweden) · 2025
Article

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Anna AnttalainenMedaffcon Oy, 02130 Espoo, Finland.ORCID 0000-0002-4041-8044

Paavo PietarinenAmgen AB, 02150 Espoo, Finland.

Samuli TuominenMedaffcon Oy, 02130 Espoo, Finland.ORCID 0000-0002-1879-0739

Riikka MattilaMedaffcon Oy, 02130 Espoo, Finland.

Aino MutkaDepartment of Pathology, University of Helsinki and Helsinki University Hospital, 00290 Helsinki, Finland.ORCID 0000-0002-2885-3211

Aija KnuuttilaDepartment of Pulmonary Medicine, Heart and Lung Center and Cancer Center, Helsinki University Hospital, 00290 Helsinki, Finland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

While

Indexed as

Carcinoma, Non-Small-Cell LungLung NeoplasmsMutationProto-Oncogene Proteins p21(ras)AdultAgedAged, 80 and overFemaleFinlandHigh-Throughput Nucleotide SequencingHumansMaleMiddle AgedRetrospective StudiesKRAS protein, humanProto-Oncogene Proteins p21(ras)KRASlung cancerNSCLCreal-world evidence

Identifiers

PMID38785486

DOI10.3390/curroncol31050205

PMCPMC11120216

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.